Navigation Links
Creation of a new material capable of eliminating pollutants by the hydrocarbon industry
Date:2/26/2008

This release is available in Spanish.

A research team of the University of Granada has managed to produce the most useful material to date to eliminate pollutants such as benzene, toluene and xylene, organic solvents widely used in the hydrocarbon industry and generated by road traffic in cities. The world-wide problem of the exposure to aromatic hydrocarbons has mainly focused its attention on benzene, which is considered to be harmful to health, even in low concentrations.

This material is a monolithic carbon aerogel with the advantage of not only being able to retain these pollutants: it can also be easily regenerated and can therefore be used in several cycles. This research has been carried out by David Fairn Jimnez, from the Department of Inorganic Chemistry at the University of Granada, and directed by lecturers Carlos Moreno Castilla and Francisco Carrasco Marn. The aim of this study was to prepare and describe a series of new materials monolithic carbon aerogels as adsorbers of benzene, tolene and xylene (BTX).

Highly Pollutant

The study of the elimination of volatile organic compounds from anthropogenic sources road traffic in cities, solvents, industry, etc. such as BTX, is very important as these substances are highly pollutant. In order to eliminate these pollutants, it is necessary to use materials with a high concentration of micropores, which is where the absorption of pollutants takes place, but these pores must be the correct size and properly arranged. Thus, we achieve a high level of efficiency when eliminating and retrieving BTX after the saturation of the material, said David Fairn.

Furthermore, the design of the adsorbent bed must allow a sufficient contact for the elimination of co
'/>"/>

Contact: David Fairn Jimnez
fairen@ugr.es
44-750-476-5078
Universidad de Granada
Source:Eurekalert  

Page: 1 2

Related biology news :

1. MIT aids creation of neural prosthetic devices
2. Canada provides $1.4M for removal of hazardous trees from provincial recreation sites
3. Lensless camera uses X-rays to view nanoscale materials and biological specimens
4. Sea cliff erosion, hemp construction materials and more at UCSD Engineering Conference
5. Material Technologies Holds First Electrochemical Fatigue Sensor Training for Private Inspection Firms
6. Genetic material under a magnifying glass
7. Ecologists, material scientists pursue genetics of diatoms elegant, etched casing
8. Purdue researchers obtain a snapshot clarifying how materials enter cells
9. Scientists discover record-breaking hydrogen storage materials for use in fuel cells
10. New Delft material concept for aircraft wings could save billions
11. Keck Foundation funds study of biological interactions with nanomaterials

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Creation of a new material capable of eliminating pollutants by the hydrocarbon industry
Creation of a new material capable of eliminating pollutants by the hydrocarbon industry
(Date:11/4/2009)...t Norman has received more than $10 million in res... the federal stimulus program, bringing thetotal a...rs to $23 million. Thirty-three projects achieved...logy to weather. , "The university has thoughtfu...reasof scholarly excellence to federal agency prio...
(Date:11/4/2009)...PRNewswire-FirstCall/ -- Quest Diagnostics Incorpo...of diagnostic testing, information and services, a...r 30, 2009, income from continuing operations rose... $160 million, or $0.81 per diluted share, for the...ults were reduced by a $0.03 per share charge asso...
(Date:11/4/2009)... Aware, Inc. (Nasdaq: AW...nd biometrics software, today reported financial r...2009. ,, Michael Tzannes, Aware,s Chairman an...e announced an agreement to sell our DSL and home ...semiconductor company being spun out of Infineon. ...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 1Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 3EGEN Inc Announces the Promotion of Jason Fewell Ph D to Vice President of Preclinical Research and Development 13448 1EGEN Inc Announces the Promotion of Jason Fewell Ph D to Vice President of Preclinical Research and Development 13448 2NeurogesX Reports Second Quarter 2009 Results 13446 1NeurogesX Reports Second Quarter 2009 Results 13446 2NeurogesX Reports Second Quarter 2009 Results 13446 3NeurogesX Reports Second Quarter 2009 Results 13446 4NeurogesX Reports Second Quarter 2009 Results 13446 5NeurogesX Reports Second Quarter 2009 Results 13446 6NeurogesX Reports Second Quarter 2009 Results 13446 7NeurogesX Reports Second Quarter 2009 Results 13446 8NeurogesX Reports Second Quarter 2009 Results 13446 9NeurogesX Reports Second Quarter 2009 Results 13446 10NeurogesX Reports Second Quarter 2009 Results 13446 11NeurogesX Reports Second Quarter 2009 Results 13446 12
...rrow Neurological Institute at St. Joseph,s Hospit...k between eye motions and the perception of illuso...Stephen Macknik, PhD, director of the Laboratory o...e, PhD, director of the Laboratory of Visual Neuro...illan; conducted a study based on the Enigma paint...
... have grown soybeans and turned them into many use...hy a soybean grows, blooms or produces like it doe... , University of Georgia professor Wayne Parrott...million grant from the National Science Foundation...ue. , "I,m convinced that soybeans would be so mu...
... city dwellers posed by Southern California wildfi...restimated by officials. , Detailed particulate a...ia wild fires indicates that the composition posed...generally realized, according to a new paper analy...thern California. , The paper, entitled "Physico...
Other Biology News:Soybean grant gives researchers tools to unravel better bean 2Where there's wildfire smoke, there's toxicity 2
(Date:11/9/2009).... 9 NexBio, Inc. announced the pre...College of Allergy, Asthma, and Immunology in Miam... (Fludase®), a Sialidase, Decreases Airway Re...in Animal Models of Asthma". ,, DAS181 (Fludase...t-targeting drug candidate being studied in human ...
(Date:11/9/2009)...vember 9 Following the provision o...Drug Administration (FDA), privately,owned UK comp...international.com ) has been informed that its inn...n awarded an Orphan-Drug,designation for the treat..., ALS, also known as Lou Gehrig,s disease, is ...
(Date:11/6/2009)...6 /PRNewswire-FirstCall/ - Microbix Biosystems Inc...iled the Form 52-109F1 Certification of Annual Fil...r and James Long, the Chief Financial Officer (the...in connection with the annual audited financial st..., The Company initially filed the annual financi...
(Date:11/6/2009)...stria, November 6 EUCODIS Bioscien...ng, and marketing enzymes for the,chemical industr...rch,agreement with Bio Sidus, the leading biopharm... agreement gives EUCODIS Bioscience exclusive acce...o Sidus, proprietary collection of,psychrophilic b...
Breaking Biology Technology:NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
...ed for the First Time on 50 mg/Day Dose for PRISTI...ssive Disorder, COLLEGEVILLE, Pa., Dec. 12 Wyeth...), announces that data from,two Phase 3 clinical s...gational serotonin-norepinephrine reuptake inhibit... a 50 mg/day dose of PRISTIQ for the,treatment of ...
...he Netherlands, December 12 , - Forty-five Presti...Response to Customer Demand, Elsevier, a leading ...M) information, today announced that 45 French-lan...e available on ScienceDirect beginning January,3, ...gie, Journal de Chirurgie and,La Press Medicale, r...
...IND has Been Filed With the FDA for the Fourth Gen...Collaboration with Roche., COPENHAGEN, December 1...nvestigational New Drug application (IND) for a,Ge...oration with Roche has,been filed with the FDA by ...velopment of the antibody which selectively blocks...
Other Biology Technology:New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 2New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 3New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 4New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 5New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 6ScienceDirect to Host French-Language Journals from Elsevier Masson 2ScienceDirect to Host French-Language Journals from Elsevier Masson 3Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic 2Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic 3
Iscove's Modified Dulbecco's Medium (IMDM) from Sigma-Aldrich
Nutrient Mixture F-12 Ham, Coon's Modification (Ham's F-12 Coon's) from Sigma-Aldrich
...solution is an isotonic, balanced salt solution. I...ervative, which permits the storage of whole blood... weeks.1 For usage, an equal volume of blood is co...y, but thoroughly, mixed. The solution is placed i...
...Mix or individual RNA sequences from high throughp...om small RNAs from LC Sciences. These products pro...ons) of DESIGNED sequences delivered in a microtub...taining a single verified RNA sequence. This is a ...
Biology Products: